Home-grown start-up Mirxes is going places, but co-founder is firmly rooted in Singapore. Read more at straitstimes.com. Read ...

In 2000, Singapore embarked on an ambitious mission to establish itself as a leading biotech hub. The government identified biomedical research as the “fourth pillar” of its economy through ...

In Singapore, one biotech company is changing how we approach cancer treatment. CytoMed Therapeutics (NASDAQ: GDTC), just launched its ANGELICA clinical trial, to fundamentally change how we make ...

Singapore hopes to become the R&D and manufacturing hub for the East Asian biotechnology industry, but it may find that its past success in IT does not predict future success in biotechnology.

This year marked a significant milestone with a doubling of applicants compared to last year, reflecting burgeoning interest in the industry and the vibrancy of Singapore's biotech ecosystem.

NEW YORK/SAN FRANCISCO: Singapore healthcare and biotech companies are making a bigger play in overseas markets like the United States, drawn by the country’s large market size and resources.

SINGAPORE biotech startups are struggling through a sharp drop in funding as investors seek greater certainty of returns. Biotech startups often go through years of research and development before ...

THE shortage of biotech talent in Singapore is set to widen by 29.2 per cent over the next decade as the sector expands, according to a report released by deep tech investor SGInnovate on Monday (Dec ...

SINGAPORE - Singapore biotech firm Mirxes launched its initial public offering (IPO) in Hong Kong on May 15, aiming to raise HK$1.09 billion (S$181 million) to support stronger growth in the ...

If successful, Mirxes will be the largest biotech listing from Singapore on the HKEx. Singapore biotech firm Mirxes has refiled its draft prospectus for a Hong Kong IPO, with a target to raise at ...

Biotechnology start-up TurtleTree wants to change the way people consume milk. Cows are out – at least as far as milking goes. The replacement: cell-based milk. The company says it is able to ...

At least five companies from mainland China or Hong Kong are planning IPOs, dual listings, or share placements in Singapore ...